{'fraction_non_alphanumeric': 0.03395585738539898, 'fraction_numerical': 0.010186757215619695, 'mean_word_length': 6.375, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Prenatal BACs‐on‐BeadsTM: the prospective experience of five prenatal diagnosis laboratories

We previously reported on the validation of Prenatal BACs‐on‐BeadsTM on retrospectively selected and prospective prenatal samples. This bead‐based multiplex assay detects chromosome 13, 18, 21 and X/Y aneuploidies and the nine most frequent microdeletion syndromes. We demonstrated that Prenatal BACs‐on‐BeadsTM is a new‐generation, prenatal screening tool. Here, we describe the experience of five European prenatal diagnosis laboratories concerning the ongoing use of Prenatal BACs‐on‐BeadsTM.